Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Bruker Corp (BRKR)

Bruker Corp (BRKR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,767,776
  • Shares Outstanding, K 145,335
  • Annual Sales, $ 2,965 M
  • Annual Income, $ 427,200 K
  • 60-Month Beta 1.17
  • Price/Sales 3.95
  • Price/Cash Flow 22.55
  • Price/Book 8.00
Trade BRKR with:

Options Overview Details

View History
  • Implied Volatility 39.73% ( -1.18%)
  • Historical Volatility 29.18%
  • IV Percentile 89%
  • IV Rank 71.40%
  • IV High 45.84% on 10/19/23
  • IV Low 24.47% on 08/25/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 6
  • Volume Avg (30-Day) 175
  • Put/Call OI Ratio 0.20
  • Today's Open Interest 3,905
  • Open Int (30-Day) 3,356

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 0.46
  • Number of Estimates 7
  • High Estimate 0.49
  • Low Estimate 0.45
  • Prior Year 0.64
  • Growth Rate Est. (year over year) -28.13%

Price Performance

See More
Period Period Low Period High Performance
1-Month
77.08 +5.05%
on 04/22/24
94.52 -14.34%
on 03/28/24
-11.43 (-12.37%)
since 03/26/24
3-Month
68.66 +17.93%
on 02/12/24
94.86 -14.64%
on 03/21/24
+9.00 (+12.51%)
since 01/26/24
52-Week
53.79 +50.53%
on 10/30/23
94.86 -14.64%
on 03/21/24
+3.48 (+4.49%)
since 04/26/23

Most Recent Stories

More News
Chart of the Day: Bruker Measures Up

The Chart of the Day belongs to the medical instruments company Bruker (BRKR) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals,...

BRKR : 80.97 (+0.47%)
Bruker: Q4 Earnings Snapshot

Bruker: Q4 Earnings Snapshot

BRKR : 80.97 (+0.47%)
Bruker: Q3 Earnings Snapshot

Bruker: Q3 Earnings Snapshot

BRKR : 80.97 (+0.47%)
PhenomeX Inc. Announces Commencement of Cash Tender Offer by Bruker

/PRNewswire/ -- PhenomeX Inc. (Nasdaq: CELL) today announced that Bruker Corporation (Nasdaq: BRKR) has commenced, through its wholly owned subsidiary, Bird...

CELL : 0.9981 (+0.31%)
BRKR : 80.97 (+0.47%)
Bruker: Q2 Earnings Snapshot

Bruker: Q2 Earnings Snapshot

BRKR : 80.97 (+0.47%)
Bruker's (BRKR) New Buyout to Advance Digital Transformation

Bruker's (BRKR) IDS division expands its unique vendor-agnostic software solutions portfolio by integrating ZONTAL with the Mestrelab Research and Arxspan scientific software solutions.

JNJ : 146.14 (-0.46%)
ISRG : 375.33 (+0.59%)
EW : 86.43 (-1.80%)
BRKR : 80.97 (+0.47%)
Bruker Announces Acquisition of ZONTAL to Advance the Digital Laboratory Transformation and Integrated Biopharma Data Solutions

Bruker Corporation (Nasdaq: BRKR) today announced that is has closed the acquisition of ZONTAL Inc . ( www.zontal.io ), an innovative platform provider for the digital transformation of the analytical...

BRKR : 80.97 (+0.47%)
Bruker (BRKR) Tops Q1 Earnings Estimates, Raises '23 Outlook

Bruker (BRKR) delivers a year-over-year revenue increase across all its segments in the first quarter, led by the strong demand for differentiated, high-performance scientific instruments and life-science...

BRKR : 80.97 (+0.47%)
JNJ : 146.14 (-0.46%)
ISRG : 375.33 (+0.59%)
EW : 86.43 (-1.80%)
Bruker (BRKR) Beats Q1 Earnings and Revenue Estimates

Bruker (BRKR) delivered earnings and revenue surprises of 16.36% and 7.44%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

BRKR : 80.97 (+0.47%)
PKI : 115.24 (-0.91%)
Bruker: Q1 Earnings Snapshot

Bruker: Q1 Earnings Snapshot

BRKR : 80.97 (+0.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science...

See More

Key Turning Points

3rd Resistance Point 83.79
2nd Resistance Point 82.88
1st Resistance Point 81.92
Last Price 80.97
1st Support Level 80.05
2nd Support Level 79.14
3rd Support Level 78.18

See More

52-Week High 94.86
Last Price 80.97
Fibonacci 61.8% 79.17
Fibonacci 50% 74.32
Fibonacci 38.2% 69.48
52-Week Low 53.79

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar